$30.06
0.000.00%
Pre-Market: Apr 4, 4:00 PM EDT
Comments
Loading...
Alkermes Insider Trading Activity | NASDAQ:ALKS | Benzinga
Track the latest Alkermes insider trading activity. Stay informed on recent buys, sells, and market impact for Alkermes stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Alkermes PLC Insiders Doing?
Insiders have report no purchases/sales in the last 30 days.
Notable Recent Insider Buys and Sales
- On January 31, 2025, Craig C Hopkinson, the company's EVP R&D, CHIEF MEDICAL OFFICER sold 3.29K shares for $27.13 each.
- On February 14, 2025, Craig C Hopkinson, the company's EVP R&D, CHIEF MEDICAL OFFICER sold 5.73K shares for $28.98 each.
Ownership Statistics for Alkermes PLC
Shares Outstanding
162.614M
Insider Shares Owned
3.625M
Insider Percentage Owned
2.23%
Institutional Shares Held
125.550M
Institutional Percentage Held
77.2%
| Feb 28, 2025 | Samuel Joseph Parisi | VP, FINANCE (INTERIM PAO) | 0.00 | $34.23 | -$94.01K | SELL-OPTIONS | 0.00% | 7.72K | Feb 26 - Feb 28 | View |
| Feb 25, 2025 | Samuel Joseph Parisi | VP, FINANCE (INTERIM PAO) | 0.00 | $35.28 | -$190.43K | SELL-OPTIONS | 0.00% | 7.72K | Feb 22 - Feb 25 | View |
| Feb 20, 2025 | Samuel Joseph Parisi | VP, FINANCE (INTERIM PAO) | 0.00 | $35.76 | -$72.71K | SELL-OPTIONS | 0.00% | 7.72K | Feb 18 - Feb 20 | View |
| Feb 14, 2025 | Craig C Hopkinson | EVP R&D, CHIEF MEDICAL OFFICER | -5.72K | $28.98 | -$3.59M | SELL | -9.00% | 57.88K | Feb 12 - Feb 13 | View |
| Jan 31, 2025 | Craig C Hopkinson | EVP R&D, CHIEF MEDICAL OFFICER | -3.29K | $27.13 | -$1.07M | SELL | -6.91% | 44.29K | Jan 30 | View |
| Dec 09, 2024 | Craig C Hopkinson | EVP R&D, CHIEF MEDICAL OFFICER | -12.15K | $27.39 | -$849.15K | SELL | -20.35% | 47.58K | Dec 09 | View |
| Dec 09, 2024 | Cato T Laurencin | DIRECTOR | 3.21K | $27.13 | -$55.25K | SELL-OPTIONS | 16.18% | 23.01K | Dec 08 - Dec 09 | View |
| Dec 05, 2024 | Craig C Hopkinson | EVP R&D, CHIEF MEDICAL OFFICER | -9.22K | $31.50 | -$290.46K | SELL | -13.37% | 59.73K | Dec 05 | View |
| Dec 04, 2024 | Craig C Hopkinson | EVP R&D, CHIEF MEDICAL OFFICER | -14.35K | $30.77 | -$441.55K | SELL | -17.23% | 68.95K | Dec 04 | View |
| Nov 27, 2024 | Christian Todd Nichols | SVP, CHIEF COMMERCIAL OFFICER | -5.21K | $29.15 | -$151.81K | SELL | -7.90% | 60.70K | Nov 27 | View |
| Nov 12, 2024 | Craig C Hopkinson | EVP R&D, CHIEF MEDICAL OFFICER | -15.94K | $25.05 | -$912.12K | SELL | -16.06% | 83.30K | Nov 11 | View |
| Nov 06, 2024 | Craig C Hopkinson | EVP R&D, CHIEF MEDICAL OFFICER | -10.47K | $29.53 | -$309.17K | SELL | -9.54% | 99.24K | Nov 06 | View |
| Mar 18, 2024 | Christian Todd Nichols | SVP, CHIEF COMMERCIAL OFFICER | -10.42K | $28.10 | -$292.74K | SELL | -13.65% | 65.91K | Mar 18 | View |
| Feb 27, 2024 | Samuel Joseph Parisi | VP, FINANCE (INTERIM PAO) | -948.00 | $29.63 | -$95.75K | SELL | -10.94% | 7.72K | Feb 23 - Feb 27 | View |
| Feb 16, 2024 | Cato T Laurencin | DIRECTOR | 0.00 | $27.19 | -$25.10K | SELL-OPTIONS | 0.00% | 15.17K | Feb 15 | View |
| Jun 08, 2023 | Cato T Laurencin | DIRECTOR | 0.00 | $27.41 | -$23.43K | SELL-OPTIONS | 0.00% | 7.48K | Jun 08 | View |
| Jun 07, 2023 | Cato T Laurencin | DIRECTOR | 0.00 | $27.23 | -$23.88K | SELL-OPTIONS | 0.00% | 7.48K | Jun 07 | View |
| May 30, 2023 | Christian Todd Nichols | SVP, CHIEF COMMERCIAL OFFICER | -7.50K | $24.68 | -$383.74K | SELL | -15.47% | 40.98K | May 30 | View |
| May 10, 2023 | Nancy Wysenski | DIRECTOR | 0.00 | $31.19 | -$4.67K | SELL-OPTIONS | 0.00% | 27.07K | May 09 | View |
| Nov 16, 2022 | David Angelo Daglio, Jr. | DIRECTOR | 35.00K | $23.31 | $815.73K | BUY | 62.81% | 90.72K | Nov 14 | View |
| Jun 21, 2022 | Christian Todd Nichols | SVP, CHIEF COMMERCIAL OFFICER | -7.47K | $28.26 | -$211.20K | SELL | -26.22% | 21.04K | Jun 21 | View |
| May 19, 2022 | Michael J Landine | SVP, CORP DEV., ALKERMES, INC. | 0.00 | $22.85 | -$629.98K | SELL-OPTIONS | 0.00% | 232.31K | May 17 | View |
| May 12, 2022 | Michael J Landine | SVP, CORP DEV., ALKERMES, INC. | 0.00 | $21.88 | -$266.63K | SELL-OPTIONS | 0.00% | 232.31K | May 10 | View |
| May 06, 2022 | Richard F Pops | DIRECTOR AND CEO, ALKERMES PLC | 102.74K | $22.27 | -$2.27M | SELL-OPTIONS | 11.87% | 968.30K | May 05 - May 06 | View |
| May 03, 2022 | Michael J Landine | SVP, CORP DEV., ALKERMES, INC. | 0.00 | $22.58 | -$301.67K | SELL-OPTIONS | 0.00% | 232.31K | May 03 | View |
| May 03, 2022 | Shane Cooke | DIRECTOR | 0.00 | $22.89 | -$126.83K | SELL-OPTIONS | 0.00% | 90.48K | May 02 | View |
| Apr 27, 2022 | Shane Cooke | DIRECTOR | 0.00 | $22.22 | -$113.35K | SELL-OPTIONS | 0.00% | 90.48K | Apr 25 | View |
| Apr 22, 2022 | Blair C. Jackson | EVP, CHIEF OPERATING OFFICER | 0.00 | $23.08 | -$652.85K | SELL-OPTIONS | 0.00% | 87.92K | Apr 20 | View |
| Apr 19, 2022 | Shane Cooke | DIRECTOR | 0.00 | $22.71 | -$123.25K | SELL-OPTIONS | 0.00% | 90.48K | Apr 18 | View |
| Apr 12, 2022 | Shane Cooke | DIRECTOR | 0.00 | $22.91 | -$127.10K | SELL-OPTIONS | 0.00% | 90.48K | Apr 11 | View |
| Apr 05, 2022 | Shane Cooke | DIRECTOR | 0.00 | $22.37 | -$116.34K | SELL-OPTIONS | 0.00% | 90.48K | Apr 04 | View |
| Mar 08, 2022 | Nancy Snyderman | DIRECTOR | 427.00 | $23.43 | $10.00K | BUY | 4.78% | 9.37K | Mar 04 | View |
| Feb 24, 2022 | Craig C Hopkinson | EVP R&D, CHIEF MEDICAL OFFICER | -11.98K | $24.76 | -$296.65K | SELL | -39.97% | 17.99K | Feb 23 | View |
| Feb 23, 2022 | Craig C Hopkinson | EVP R&D, CHIEF MEDICAL OFFICER | 18.18K | $25.08 | -$271.65K | SELL-OPTIONS | 154.00% | 29.98K | Feb 18 - Feb 22 | View |
| Aug 24, 2021 | Emily Peterson Alva | DIRECTOR | 1.65K | $30.22 | $49.86K | BUY | ∞ | 1.65K | Aug 23 | View |
| Aug 20, 2021 | Iain M. Brown | SVP, CHIEF FINANCIAL OFFICER | 0.00 | $23.27 | -$537.60K | SELL-OPTIONS | 0.00% | 42.98K | Aug 19 | View |
| Aug 04, 2021 | Brian P McKeon | DIRECTOR | 10.00K | $26.43 | $264.27K | BUY | ∞ | 10.00K | Aug 02 | View |
| Jul 30, 2021 | David J. Gaffin | SVP, CLO, ALKERMES, INC. | 0.00 | $21.27 | -$132.30K | SELL-OPTIONS | 0.00% | 74.60K | Jul 29 | View |
| Jul 02, 2021 | David W Anstice | DIRECTOR | 0.00 | $19.59 | -$199.50K | SELL-OPTIONS | 0.00% | 73.08K | Jul 01 | View |
| Jun 11, 2021 | David J. Gaffin | SVP, CLO, ALKERMES, INC. | 0.00 | $20.77 | -$114.08K | SELL-OPTIONS | 0.00% | 74.60K | Jun 10 | View |
| Jun 11, 2021 | Wendy L Dixon | DIRECTOR | 0.00 | $21.61 | -$169.75K | SELL-OPTIONS | 0.00% | 41.30K | Jun 10 | View |
| Jun 11, 2021 | Craig C Hopkinson | EVP R&D, CHIEF MEDICAL OFFICER | -882.00 | $24.60 | -$21.70K | SELL | -100.00% | 0.00 | Jun 09 | View |
| Jun 08, 2021 | David J. Gaffin | SVP, CLO, ALKERMES, INC. | 0.00 | $20.27 | -$100.58K | SELL-OPTIONS | 0.00% | 74.60K | Jun 07 | View |
| Jun 08, 2021 | David W Anstice | DIRECTOR | 0.00 | $19.30 | -$47.00K | SELL-OPTIONS | 0.00% | 73.08K | Jun 07 | View |
| May 19, 2021 | Richard F Pops | DIRECTOR AND CEO, ALKERMES PLC | 0.00 | $20.00 | -$569.65K | SELL-OPTIONS | 0.00% | 792.04K | May 18 | View |
| May 19, 2021 | Michael J Landine | SVP, CORP DEV., ALKERMES, INC. | 0.00 | $20.10 | -$199.40K | SELL-OPTIONS | 0.00% | 216.78K | May 17 | View |
| May 14, 2021 | David J. Gaffin | SVP, CLO, ALKERMES, INC. | 0.00 | $20.17 | -$9.28K | SELL-OPTIONS | 0.00% | 74.60K | May 14 | View |
| May 14, 2021 | Michael J Landine | SVP, CORP DEV., ALKERMES, INC. | 0.00 | $20.25 | -$107.07K | SELL-OPTIONS | 0.00% | 216.78K | May 13 | View |
| May 12, 2021 | Richard F Pops | DIRECTOR AND CEO, ALKERMES PLC | 0.00 | $20.10 | -$597.59K | SELL-OPTIONS | 0.00% | 792.04K | May 11 | View |
| May 07, 2021 | Michael J Landine | SVP, CORP DEV., ALKERMES, INC. | 0.00 | $20.10 | -$77.89K | SELL-OPTIONS | 0.00% | 216.78K | May 07 | View |
| May 07, 2021 | Richard F Pops | DIRECTOR AND CEO, ALKERMES PLC | 0.00 | $19.95 | -$368.91K | SELL-OPTIONS | 0.00% | 792.04K | May 06 | View |
| May 04, 2021 | Blair C. Jackson | EVP, CHIEF OPERATING OFFICER | 0.00 | $20.14 | -$140.48K | SELL-OPTIONS | 0.00% | 68.15K | May 03 | View |
| Apr 20, 2021 | Wendy L Dixon | DIRECTOR | 0.00 | $17.30 | -$135.12K | SELL-OPTIONS | 0.00% | 36.60K | Apr 19 | View |
| Apr 20, 2021 | Iain M. Brown | SVP, CHIEF FINANCIAL OFFICER | 0.00 | $19.05 | -$66.24K | SELL-OPTIONS | 0.00% | 48.36K | Apr 16 - Apr 19 | View |
| Apr 16, 2021 | Craig C Hopkinson | EVP R&D, CHIEF MEDICAL OFFICER | -28.92K | $19.72 | -$570.29K | SELL | -100.00% | 0.00 | Apr 15 | View |
| Oct 05, 2020 | David W Anstice | — | 2.17K | $15.85 | -$910.12 | OPTION EXERCISE | 3.27% | 68.38K | Sep 28 | View |
| Oct 02, 2020 | Paul J Mitchell | — | 0.00 | $15.77 | -$33.86K | OPTION EXERCISE | 0.00% | 15.00K | Oct 01 | View |
| May 14, 2020 | Richard F Pops | — | 0.00 | $13.37 | -$244.73K | OPTION EXERCISE | 0.00% | 759.09K | May 14 | View |
| May 14, 2020 | Iain M. Brown | — | 0.00 | $13.57 | -$22.82K | OPTION EXERCISE | 0.00% | 38.58K | May 13 | View |
| May 14, 2020 | Michael J Landine | — | 0.00 | $13.74 | -$72.15K | OPTION EXERCISE | 0.00% | 201.82K | May 12 | View |
| May 07, 2020 | Richard F Pops | — | 0.00 | $13.18 | -$144.26K | OPTION EXERCISE | 0.00% | 759.09K | May 07 | View |
| May 07, 2020 | Michael J Landine | — | 0.00 | $12.90 | -$57.92K | OPTION EXERCISE | 0.00% | 201.82K | May 05 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.